Results 21 to 30 of about 8,070 (69)
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
Vaccines, 2023 Dengue fever, an infectious disease that affects more than 100 million people every year, is a global health problem. Vaccination may be the most effective prevention strategy for the disease.
Ramil R. Mintaev +6 more
doaj +1 more source
Journal of Infection and Public Health, 2019 Background: Dengue is a rapidly emerging arthropod borne viral infection affecting tropical and sub-tropical regions of the world. Dengue is an acute febrile illness but sometimes causes more fatal complications like dengue haemorrhagic fever (DHF) and ...
Nazish Parveen +9 more
doaj +1 more source
Polytope Prediction for Dengue Vaccine Candidate Based on Conserved Envelope Glycoprotein of Four Serotypes of Dengue Virus and Its Antigenicity [PDF]
Journal of Pure and Applied Chemistry Research, 2016 Dengue fever reported endemic in tropical and sub-tropical country. Dengue fever caused by dengue virus, has Envelope protein that often used for vaccine development to prevent the virus infection.
Karimatul Himmah +4 more
doaj +1 more source
Frontiers in Microbiology, 2022 In the past decade, dengue virus infection is one of the most prevalent and rapidly spreading arthropod-borne diseases worldwide with about 400 million infections every year.
Yaoxing Wu +7 more
doaj +1 more source
The monocyte-macrophage-mast cell axis in dengue pathogenesis
Journal of Biomedical Science, 2018 Dengue virus, the causative agent of dengue disease which may have hemorrhagic complications, poses a global health threat. Among the numerous target cells for dengue virus in humans are monocytes, macrophages and mast cells which are important ...
Shu-Wen Wan +5 more
doaj +1 more source
Reverse genetics rescue of sylvatic dengue viruses
Journal of VirologyThere are an unknown number of sylvatic (“sylvan” = “of the forest”) dengue viruses currently being sustained by nonhuman primates and mosquitoes in the forests of Africa and Asia.
Paul Gendler +6 more
doaj +1 more source
Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014–2015
Emerging Infectious Diseases, 2018 We investigated dengue and chikungunya virus antibody seroprevalence in French Polynesia during 2014–2015. Dengue virus seroprevalence was ≈60% among schoolchildren and >83% among the general population; chikungunya virus seroprevalence was
Maite Aubry +18 more
doaj +1 more source
Microorganisms, 2023 Dengue virus infections are recorded as hyper-endemic in many countries, including India. Research pertaining to the reasons for frequent outbreaks and severe dengue is ongoing.
Deepti Maisnam +3 more
doaj +1 more source
Aceh International Journal of Science and Technology, 2014 The purposes of this research were to determine the prevalence of dengue virus in the study population, to determine the relationship between the occurrence of dengue virus IgM and potential risk factors and to determine the association between the ...
Matthew O. Idoko +2 more
doaj +1 more source
REVIEW ARTICLE: DEVELOPEMENT AND USING DENGUE VACCINE FOR DENGUE INFECTION VIRUS
Medical and Health Science Journal, 2019 : Tropical and subtropical countries are regions with high incidence of dengue infection. Dengue virus infection is estimated to cause 300 million new infections in one year and approximately 1 million severe cases with 2 + 5% deaths.
Firdaus Kabiru Massey, Rika Yulia
doaj +1 more source